Mismatch Negativity (MMN) as a Pharmacodynamic/Response Biomarker for NMDA Receptor and Excitatory/Inhibitory Imbalance-Targeted Treatments in Schizophrenia

Javitt, D. C. (2024). Mismatch Negativity (MMN) as a Pharmacodynamic/Response Biomarker for NMDA Receptor and Excitatory/Inhibitory Imbalance-Targeted Treatments in Schizophrenia. Neurophysiologic Biomarkers in Neuropsychiatric Disorders, 411–451. https://doi.org/10.1007/978-3-031-69491-2_15
Authors:
Daniel C Javitt
Affiliated Authors:
Daniel C Javitt
Columbia Affiliation:
Subjects:
Schizophrenia (MeSH)
Receptors, N-Methyl-D-Aspartate (MeSH)
Author Keywords:
auditory
cognition
event-related potentials
nmda receptor
negative symptoms
schizophrenia
tone-matching
elink
Publication Type:
Article
Unique ID:
10.1007/978-3-031-69491-2_15
PMID:
39562453
DOI:
10.1007/978-3-031-69491-2_15
Journal:
Advances in Neurobiology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: